{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:58:15Z","timestamp":1783400295555,"version":"3.54.6"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,5]],"date-time":"2015-10-05T00:00:00Z","timestamp":1444003200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12906-015-0871-5","type":"journal-article","created":{"date-parts":[[2015,10,5]],"date-time":"2015-10-05T12:54:34Z","timestamp":1444049674000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Extracts from Aralia elata (Miq) Seem alleviate hepatosteatosis via improving hepatic insulin sensitivity"],"prefix":"10.1186","volume":"15","author":[{"given":"Kyung-A","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jin","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga Ram","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Sook","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,5]]},"reference":[{"key":"871_CR1","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1053\/gast.2002.33573","volume":"122","author":"JM Clark","year":"2002","unstructured":"Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology. 2002;122:1649\u201357.","journal-title":"Gastroenterology"},{"key":"871_CR2","first-page":"1416","volume":"62","author":"R Pais","year":"2012","unstructured":"Pais R, Ratziu V. Epidemiology and natural history of nonalcoholic fatty liver disease. La Revue du Praticien. 2012;62:1416\u201321.","journal-title":"La Revue du Praticien"},{"key":"871_CR3","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cgh.2012.03.011","volume":"10","author":"DM Torres","year":"2012","unstructured":"Torres DM, Williams CD, Harrison SA. Features, diagnosis, and treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2012;10:837\u201358.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"871_CR4","first-page":"351","volume":"20","author":"M Kohjima","year":"2007","unstructured":"Kohjima M, Enjoji M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, et al. Reevaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int J Mol Med. 2007;20:351\u20138.","journal-title":"Int J Mol Med"},{"key":"871_CR5","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","volume":"116","author":"CA Matteoni","year":"1999","unstructured":"Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413\u20139.","journal-title":"Gastroenterology"},{"key":"871_CR6","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1126\/science.1204265","volume":"332","author":"JC Cohen","year":"2011","unstructured":"Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: old questions and new insights. Science. 2011;332:1519\u201323.","journal-title":"Science"},{"key":"871_CR7","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1210\/jc.2006-0587","volume":"91","author":"KM Utzschneider","year":"2006","unstructured":"Utzschneider KM, Kahn SE. The role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2006;91:4753\u201361.","journal-title":"J Clin Endocrinol Metab"},{"key":"871_CR8","doi-asserted-by":"publisher","first-page":"582","DOI":"10.18632\/aging.100585","volume":"5","author":"T Galbo","year":"2013","unstructured":"Galbo T, Shulman GI. Lipid-induced hepatic insulin resistance. Aging. 2013;5:582\u20133.","journal-title":"Aging"},{"key":"871_CR9","first-page":"1153","volume":"3","author":"GT Keith","year":"2007","unstructured":"Keith GT, Anthony SD. Treatment of non-alcoholic fatty liver disease. J Ther Clin Risk Manage. 2007;3:1153\u201363.","journal-title":"J Ther Clin Risk Manage"},{"key":"871_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4254\/wjh.v6.i4.199","volume":"6","author":"ZA Ozturk","year":"2014","unstructured":"Ozturk ZA, Kadayifci A. Insulin sensitizers for the treatment of non-alcoholic fatty liver disease. World J Hepatol. 2014;6:199\u2013206.","journal-title":"World J Hepatol"},{"key":"871_CR11","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1056\/NEJM199508313330903","volume":"333","author":"M Stumvoll","year":"1995","unstructured":"Stumvoll M, Nurjhan N, Perriello G, Dailey G, Gerich JE. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med. 1995;333:550\u20134.","journal-title":"N Engl J Med"},{"key":"871_CR12","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/79697","volume":"6","author":"HZ Lin","year":"2000","unstructured":"Lin HZ, Yang SQ, Chuckaree C, Kuhajda F, Ronnet G, Diehl AM. Metformin reverses fatty liver disease in obese, leptin deficient mice. Nat Med. 2000;6:998\u20131003.","journal-title":"Nat Med"},{"key":"871_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1463-1326.2008.00926.x","volume":"11","author":"MH Ahmed","year":"2009","unstructured":"Ahmed MH, Byrne CD. Current treatment of non-alcoholic fatty liver disease. Diabetes Obes Metab. 2009;11:188\u201395.","journal-title":"Diabetes Obes Metab"},{"key":"871_CR14","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.3390\/nu6072956","volume":"6","author":"YJ Hwang","year":"2014","unstructured":"Hwang YJ, Wi HR, Kim HR, Park KW, Hwang KA. Pinus densiflora Sieb. et Zucc. Alleviates Lipogenesis and Oxidative Stress during Oleic Acid-Induced Steatosis in HepG2 Cells. Nutrients. 2014;6:2956\u201372.","journal-title":"Nutrients"},{"key":"871_CR15","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1016\/j.fct.2011.06.071","volume":"49","author":"JS Kang","year":"2011","unstructured":"Kang JS, Lee WK, Lee CW, Yoon WK, Kim N, Park SK, et al. Improvement of high-fat diet-induced obesity by a mixture of red grape extract, soy isoflavone and L-carnitine: Implications in cardiovascular and non-alcoholic fatty liver diseases. Food Chem Toxicol. 2011;49:2453\u20138.","journal-title":"Food Chem Toxicol"},{"key":"871_CR16","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/j.phytochem.2010.07.011","volume":"71","author":"JW Yun","year":"2010","unstructured":"Yun JW. Possible anti-obesity therapeutics from nature \u2013 a review. Phytochemistry. 2010;71:1625\u201341.","journal-title":"Phytochemistry"},{"key":"871_CR17","doi-asserted-by":"crossref","unstructured":"Anh\u00ea FF, Roy D, Pilon G, Dudonn\u00e9 S, Matamoros S, Varin TV, et al. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut. 2014, doi: 10.1136\/gutjnl-2014-307142.","DOI":"10.1136\/gutjnl-2014-307142"},{"key":"871_CR18","doi-asserted-by":"crossref","unstructured":"Chiu WC, Yang HH, Chiang SC, Chou YX, Yang HT. Auricularia polytricha aqueous extract supplementation decreases hepatic lipid accumulation and improves antioxidative status in animal model of nonalcoholic fatty liver. Biomedicine (Taipei). 2014. doi: 10.7603\/s40681-014-0012-3","DOI":"10.7603\/s40681-014-0012-3"},{"key":"871_CR19","doi-asserted-by":"publisher","first-page":"738","DOI":"10.12691\/jfnr-2-10-13","volume":"2","author":"Z Xinghai","year":"2014","unstructured":"Xinghai Z, Ying G, Jinwei X, Xiaohui L, Feng J, Bo L, et al. Inhibitory Effect of Tea (Camellia Sinensis (L.) O. Kuntze, Theaceae) Flower Extracts on Oleic Acid-Induced Hepatic Steatosis in Hepg2 Cells. J Food Nutr Res. 2014;2:738\u201343.","journal-title":"J Food Nutr Res"},{"key":"871_CR20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3892\/etm.2014.1698","volume":"8","author":"Y Wan","year":"2014","unstructured":"Wan Y, Liu LY, Hong ZF, Peng J. Ethanol extract of Cirsium japonicum attenuates hepatic lipid accumulation via AMPK activation in human HepG2 cells. Exp Ther Med. 2014;8:79\u201384.","journal-title":"Exp Ther Med"},{"key":"871_CR21","first-page":"3157","volume":"20","author":"M Li","year":"2009","unstructured":"Li M, Lu W. Pharmacological research progress of Araliaelata. Medical Recapitulate. 2009;20:3157\u201360.","journal-title":"Medical Recapitulate"},{"key":"871_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.etap.2009.05.009","volume":"28","author":"JH Lee","year":"2009","unstructured":"Lee JH, Jeong CS, Lee JH, Jeong CS. Suppressive effects on the biosynthesis of inflammatory mediators by Aralia elata extract fractions in macrophage cells. Environ Toxicol Pharmacol. 2009;28:333\u201341.","journal-title":"Environ Toxicol Pharmacol"},{"key":"871_CR23","doi-asserted-by":"publisher","first-page":"6143","DOI":"10.1016\/j.bmcl.2011.08.024","volume":"21","author":"NX Nhiem","year":"2011","unstructured":"Nhiem NX, Lim HY, Kiem PV, Minh CV, Thu VK, Tai BH, et al. Oleanane-type triterpene saponins from the bark of Aralia elata and their NF-\u03baB inhibition and PPAR activation signal pathway. Bioorg Med Chem Lett. 2011;21:6143\u20137.","journal-title":"Bioorg Med Chem Lett"},{"key":"871_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0304-3835(03)00348-3","volume":"199","author":"M Tomatsu","year":"2003","unstructured":"Tomatsu M, Kameyama M, Shibamoto NA. Aralin, A new cytotoxic protein from Aralia elata, inducing apoptosis in human cancer cells. Cancer Lett. 2003;199:19\u201325.","journal-title":"Cancer Lett"},{"key":"871_CR25","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.abb.2007.08.025","volume":"467","author":"SJ Suh","year":"2007","unstructured":"Suh SJ, Jin UH, Kim KW. Triterpenoid saponin, oleanolic acid 3-O-d-glucopyranosyl(1\u2009\u2192\u20093)-alpha-l-rhamnopyranosyl(1\u2009\u2192\u20092)-alpha-l arabinopyranoside (OA) from Aralia elata inhibits LPS-induced nitric oxide production by down regulated NF-kappa B in raw 264.7 cells. Arch Biochem Biophys. 2007;467:227\u201333.","journal-title":"Arch Biochem Biophys"},{"key":"871_CR26","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3746\/jkfn.2004.33.9.1457","volume":"33","author":"KH Shin","year":"2004","unstructured":"Shin KH, Cho SY, Lee MK, Lee JS, Kim MJ. Effects of Aralia elata, Acanthopanacis cortex and Ulmus davidiana Water Extracts on Plasma Biomarkers in Streptozotocin - Induced Diabetic Rats. J Korean Soc Food Sci Nutr. 2004;33:1457\u201362.","journal-title":"J Korean Soc Food Sci Nutr"},{"key":"871_CR27","first-page":"912","volume":"28","author":"YH Kim","year":"1999","unstructured":"Kim YH, Im JG. Effect of saponin from the shoot of Aralia elata in normal rats and streptozotocin induced diabetic rats. J Korean Soc Food Sci Nutr. 1999;28:912\u20136.","journal-title":"J Korean Soc Food Sci Nutr"},{"key":"871_CR28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1210\/endo.142.1.7863","volume":"142","author":"SP Cousin","year":"2001","unstructured":"Cousin SP, H\u00fcgl SR, Wrede CE, Kajio H, Myers MG, Rhodes CJ. Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-Induced deoxyribonucleic acid synthesis in the pancreatic beta-Cell Line INS-1. Endocrinology. 2001;142:229\u201340.","journal-title":"Endocrinology"},{"key":"871_CR29","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412\u20139.","journal-title":"Diabetologia"},{"key":"871_CR30","doi-asserted-by":"publisher","first-page":"32345","DOI":"10.1074\/jbc.M313478200","volume":"279","author":"VT Samuel","year":"2004","unstructured":"Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem. 2004;279:32345\u201353.","journal-title":"J Biol Chem"},{"key":"871_CR31","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1194\/jlr.R800053-JLR200","volume":"50","author":"CA Nagle","year":"2009","unstructured":"Nagle CA, Klett EL, Coleman RA. Hepatic triacylglycerol accumulation and insulin resistance. J Lipid Res. 2009;50:S74\u20139.","journal-title":"J Lipid Res"},{"key":"871_CR32","doi-asserted-by":"publisher","first-page":"8501","DOI":"10.1016\/j.cld.2004.04.008","volume":"8","author":"CE Ruhl","year":"2004","unstructured":"Ruhl CE, Everhart JE. Epidemiology of nonalcoholic fatty liver. Clin Liver Dis. 2004;8:8501\u201319.","journal-title":"Clin Liver Dis"},{"key":"871_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jep.2009.09.055","volume":"127","author":"M Liu","year":"2010","unstructured":"Liu M, Wu K, Mao X, Wu Y, Ouyang J. Astragalus polysaccharide improves insulin sensitivity in KKAy mice: regulation of PKB\/GLUT4 signaling in skeletal muscle. J Ethnopharmacol. 2010;127:32\u20137.","journal-title":"J Ethnopharmacol"},{"key":"871_CR34","doi-asserted-by":"publisher","first-page":"33609","DOI":"10.1074\/jbc.R300019200","volume":"278","author":"Y Minokoshi","year":"2003","unstructured":"Minokoshi Y, Kahn CR, Kahn BB. Tissue-specific Ablation of the GLUT4 Glucose Transporter or the Insulin Receptor Challenges Assumptions about Insulin Action and Glucose Homeostasis. J Biol Chem. 2003;278:33609\u201312.","journal-title":"J Biol Chem"},{"key":"871_CR35","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","volume":"148","author":"VT Samuel","year":"2012","unstructured":"Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012;148:852\u201371.","journal-title":"Cell"},{"key":"871_CR36","doi-asserted-by":"publisher","first-page":"e99772","DOI":"10.1371\/journal.pone.0099772","volume":"9","author":"X Wang","year":"2014","unstructured":"Wang X, Wahl R. Responses of the insulin signaling pathway in the brown adipose tissue of rats following cold exposure. PLoS One. 2014;9:e99772.","journal-title":"PLoS One"},{"key":"871_CR37","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10565-011-9195-5","volume":"27","author":"TJ Hsieh","year":"2011","unstructured":"Hsieh TJ, Hsieh PC, Wu MT, Chang WC, Hsiao PJ, Lin KD, et al. Betel nut extract and arecoline block insulin signaling and lipid storage in 3\u00a0T3-L1 adipocytes. Cell Biol Toxicol. 2011;27:397\u2013411.","journal-title":"Cell Biol Toxicol"},{"key":"871_CR38","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.bcp.2011.01.002","volume":"81","author":"SS Choi","year":"2011","unstructured":"Choi SS, Cha BY, Iida K, Lee YS, Yonezawa T, Teruya T, et al. Artepillin C, as a PPAR\u03b3 ligand, enhances adipocyte differentiation and glucose uptake in 3\u00a0T3-L1 cells. Biochem Pharmacol. 2011;81:925\u201333.","journal-title":"Biochem Pharmacol"},{"key":"871_CR39","doi-asserted-by":"publisher","first-page":"28087","DOI":"10.1074\/jbc.274.40.28087","volume":"274","author":"PG Foran","year":"1999","unstructured":"Foran PG, Fletcher LM, Oatey PB, Mohammed N, Dolly JO, Tavare JM. Protein kinase B stimulates the translocation of GLUT4 but not GLUT1 or transferrin receptors in 3\u00a0T3-L1 adipocytes by a pathway involving SNAP-23, Synaptobrevin-2, and\/or cellubrevin. J Biol Chem. 1999;274:28087\u201395.","journal-title":"J Biol Chem"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-015-0871-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-015-0871-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-015-0871-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T07:07:34Z","timestamp":1567235254000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-015-0871-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,5]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["871"],"URL":"https:\/\/doi.org\/10.1186\/s12906-015-0871-5","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,5]]},"article-number":"347"}}